As research continues to come out Effective treatment against covid 19 Which infected millions around the world and is still harvesting more, a large British study published today, Wednesday, came out with good news, to reveal that the mixture of antibodies to…novel coronavirusThe drug, made by Regeneron, has reduced the number of deaths in hospital patients whose bodies did not produce antibodies.
The treatment, known as Regen-Cove, has been approved for emergency use in the United States for people with mild to moderate symptoms, but results from the “Recovery” trial provide the clearest evidence of its effectiveness for hospitalized patients.
The experiment also found that antibody treatment reduced the number of deaths that occurred within 28 days of establishing infection with the Corona virus by one fifth, among patients who were being treated in hospitals, and there was no response from their immune system by producing antibodies.
This result means six fewer deaths among every 100 patients with the condition who received this treatment, the researchers said.
Reduces the need for respirators
As Martin Landray, the chief researcher who participated in the experiment, told reporters, “People were very, very pessimistic about the effectiveness of any antiviral treatment, specifically for this virus, after patients were hospitalized.”
“If you don’t produce antibodies on your own, it will really help you to get some,” he added. He added that the treatment also shortened the length of stay in the hospital and reduced the likelihood of them needing respirators.
Intensive care department to treat corona patients in Texas – AFP
The Corona virus has killed 3.82 million people in the world since the World Health Organization office in China reported the emergence of the disease at the end of December 2019.
More than 177 million people have been confirmed infected with the virus since its appearance.
The United States remains the most affected country by Corona, according to official data, followed by Brazil and India.